Cathflo Activase Injection, Powder, Lyophilized, For Solution
Product Images NDC 50242-041

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Cathflo Activase (NDC 50242-041). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Genentech, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (2 mg Vial Carton)

Principal Display Panel (2 mg Vial Carton)
This is a description of the medication Cathflo Activase (alteplase), which is administered through central venous access devices. The medication is packaged with a National Drug Code (NDC) of 50242-041-64 and a US License No of 1048. The text also includes a cautionary instruction to "KEEP REFRIGERATED" and a product identification number (10165659).*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.